ArticleScientific reports2019

Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementia.

Deepthi Yedlapudi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.